![Uwe Schoenbeck](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Uwe Schoenbeck
Director/Miembro de la Junta en Alterome Therapeutics, Inc. .
Cargos activos de Uwe Schoenbeck
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Canaan Management, Inc.
![]() Canaan Management, Inc. Investment ManagersFinance Canaan Management, Inc. (Canaan Management) is a venture capital firm founded in 1987 by Eric A. Young. The firm is headquartered in Westport, CT. | Inversor de Capital Privado | - | - |
Alterome Therapeutics, Inc.
![]() Alterome Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Alterome Therapeutics, Inc. is a precision oncology biotech that develops alteration-specific therapeutics to address high-value and validated oncogenic drivers. The company is based in San Marcos, CA. The company is led by seasoned R&D leaders with a history of developing marketed oncology small molecule drugs. The company's mission is to discover precise therapies and inspire hope for individuals affected by cancer. The CEO of the company is Eric A. Murphy. | Director/Miembro de la Junta | - | - |
Historial de carrera de Uwe Schoenbeck
Estadísticas
Internacional
Estados Unidos | 3 |
Operativa
Private Equity Investor | 1 |
Director/Board Member | 1 |
Sectorial
Finance | 2 |
Health Technology | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 2 |
---|---|
Canaan Management, Inc.
![]() Canaan Management, Inc. Investment ManagersFinance Canaan Management, Inc. (Canaan Management) is a venture capital firm founded in 1987 by Eric A. Young. The firm is headquartered in Westport, CT. | Finance |
Alterome Therapeutics, Inc.
![]() Alterome Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Alterome Therapeutics, Inc. is a precision oncology biotech that develops alteration-specific therapeutics to address high-value and validated oncogenic drivers. The company is based in San Marcos, CA. The company is led by seasoned R&D leaders with a history of developing marketed oncology small molecule drugs. The company's mission is to discover precise therapies and inspire hope for individuals affected by cancer. The CEO of the company is Eric A. Murphy. | Health Technology |
- Bolsa de valores
- Insiders
- Uwe Schoenbeck
- Experiencia